Survey
* Your assessment is very important for improving the work of artificial intelligence, which forms the content of this project
* Your assessment is very important for improving the work of artificial intelligence, which forms the content of this project
PART IV Pulmonary Vascular Diseases Slide 1 Copyright © 2006 by Mosby, Inc. Chapter 19 Pulmonary Edema RBC IE FWS Figure 19-1. Pulmonary edema. Cross-sectional view of alveoli and alveolar duct in pulmonary edema. FWS, Frothy white secretions; IE, interstitial edema; RBC, red blood cell. Inset, Atelectasis, a common secondary anatomic alteration of the lungs. Slide 2 Copyright © 2006 by Mosby, Inc. Anatomic Alterations of the Lungs Slide 3 Interstitial edema, including fluid engorgement of the perivascular and peribronchial spaces and the alveolar wall interstitium Alveolar flooding Increased surface tension of pulmonary surfactant Alveolar shrinkage and atelectasis Frothy white (or pink) secretions throughout the tracheobronchial tree Copyright © 2006 by Mosby, Inc. Etiology Cardiogenic pulmonary edema Slide 4 Congestive heart failure Copyright © 2006 by Mosby, Inc. Etiology Movement of fluid in and out of the capillaries is expressed by Starling’s equation: J = K (Pc – Pi) – (c – i) where J is the net fluid movement out of the capillary, K is the capillary permeability factor, Pc and Pi are the hydrostatic pressures in the capillary and interstitial space, and c and i are the oncotic pressures in the capillary and interstitial space Slide 5 Copyright © 2006 by Mosby, Inc. Slide 6 Copyright © 2006 by Mosby, Inc. Slide 7 Copyright © 2006 by Mosby, Inc. Slide 8 Copyright © 2006 by Mosby, Inc. Etiology Noncardiogenic pulmonary edema Slide 9 Increased capillary permeability Alveolar hypoxia Acute respiratory distress syndrome Inhalation of toxic agents Pulmonary infections Therapeutic radiation of the lungs Head injury Copyright © 2006 by Mosby, Inc. Etiology Slide 10 Lymphatic insufficiency Decreased intrapleural pressure Decreased oncotic pressure Overtransfusion Uremia Hypoproteinemia Acute nephritis Polyarteritis nodosa Copyright © 2006 by Mosby, Inc. Slide 11 Copyright © 2006 by Mosby, Inc. Slide 12 Copyright © 2006 by Mosby, Inc. Overview of the Cardiopulmonary Clinical Manifestations Associated with PULMONARY EDEMA The following clinical manifestations result from the pathophysiologic mechanisms caused (or activated) by Atelectasis (see Figure 9-7), Increased Alveolar-Capillary Membrane Thickness (see Figure 9-9) and, in severe cases, Excessive Bronchial Secretions (see Figure 9-11)—the major anatomic alterations of the lungs associated with pulmonary edema (see Figure 19-1) Slide 13 Copyright © 2006 by Mosby, Inc. Figure 9-7. Atelectasis clinical scenario. Slide 14 Copyright © 2006 by Mosby, Inc. Figure 9-9. Increased alveolar-capillary membrane thickness clinical scenario. Slide 15 Copyright © 2006 by Mosby, Inc. Figure 9-11. Excessive bronchial secretions clinical scenario. Slide 16 Copyright © 2006 by Mosby, Inc. Clinical Data Obtained at the Patient’s Bedside Vital signs Slide 17 Increased respiratory rate Increased heart rate, cardiac output, blood pressure Copyright © 2006 by Mosby, Inc. Clinical Data Obtained at the Patient’s Bedside Slide 18 Cheyne-Stokes respiration Paroxysmal nocturnal dyspnea (PND) and orthopnea Cyanosis Cough and sputum (frothy and pink) Chest assessment findings Increased tactile and vocal fremitus Crackles, rhonchi, and wheezing Copyright © 2006 by Mosby, Inc. Clinical Data Obtained from Laboratory Tests and Special Procedures Slide 19 Copyright © 2006 by Mosby, Inc. Pulmonary Function Study: Expiratory Maneuver Findings FVC FEVT N or FEF25%-75% N or FEF200-1200 N PEFR MVV FEF50% FEV1% N Slide 20 N or N N or Copyright © 2006 by Mosby, Inc. Pulmonary Function Study: Lung Volume and Capacity Findings VT Slide 21 RV FRC TLC N or VC IC ERV RV/TLC% N Copyright © 2006 by Mosby, Inc. Arterial Blood Gases Mild to Moderate Pulmonary Edema pH Slide 22 Acute alveolar hyperventilation with hypoxemia PaCO2 HCO3 (Slightly) PaO2 Copyright © 2006 by Mosby, Inc. Time and Progression of Disease Disease Onset Alveolar Hyperventilation 100 90 PaO2 or PaCO2 80 Point at which PaO2 declines enough to stimulate peripheral oxygen receptors 70 60 PaO2 50 40 30 20 10 0 Figure 4-2. PaO2 and PaCO2 trends during acute alveolar hyperventilation. Slide 23 Copyright © 2006 by Mosby, Inc. Arterial Blood Gases Severe Pulmonary Edema Acute ventilatory failure with hypoxemia pH Slide 24 PaCO2 HCO3 (slightly) PaO2 Copyright © 2006 by Mosby, Inc. Time and Progression of Disease Disease Onset Alveolar Hyperventilation Acute Ventilatory Failure 100 90 Pa02 or PaC02 80 70 Point at which PaO2 declines enough to stimulate peripheral oxygen receptors Point at which disease becomes severe and patient begins to become fatigued 60 50 40 30 20 10 0 Figure 4-7. PaO2 and PaCO2 trends during acute ventilatory failure. Slide 25 Copyright © 2006 by Mosby, Inc. Oxygenation Indices QS/QT DO2 VO2 Normal O2ER Slide 26 C(a-v)O2 Normal SvO2 Copyright © 2006 by Mosby, Inc. Hemodynamic Indices (Cardiogenic Pulmonary Edema) Slide 27 CVP RAP PA PCWP CO SV SVI CI RVSWI LVSWI PVR SVR Copyright © 2006 by Mosby, Inc. Abnormal Laboratory Tests and Procedures Slide 28 Serum potassium: low Serum sodium: low Hypokalemia and hyponatremia are often seen in patients with left-sided heart failure and may result from diuretic therapy or excessive fluid retention Copyright © 2006 by Mosby, Inc. Radiologic Findings Chest radiograph Slide 29 Fluffy opacities Left ventricular hypertrophy Kerley A and B lines Pleural effusion Copyright © 2006 by Mosby, Inc. Figure 19-2. Cardiomegaly (arrow) and pulmonary edema in congestive heart failure. Slide 30 Copyright © 2006 by Mosby, Inc. General Management of Pulmonary Edema Respiratory care treatment protocols Slide 31 Oxygen therapy protocol Bronchopulmonary hygiene therapy protocol Hyperinflation therapy protocol Aerosolized medication protocol Copyright © 2006 by Mosby, Inc. General Management of Pulmonary Edema Medications and procedures commonly prescribed by the physician Slide 32 Positive inotropic agents Afterload reduction agents Morphine sulfate Diuretic agents Copyright © 2006 by Mosby, Inc. General Management of Pulmonary Edema Medications and procedures commonly prescribed by the physician Slide 33 Albumin and mannitol Alcohol (ethanol, ethyl alcohol) Decreasing hydrostatic pressure Positioning the patient in Fowler’s position Rotating tourniquets (rarely used) Phlebotomy (rarely used) Copyright © 2006 by Mosby, Inc. Classroom Discussion Case Study: Pulmonary Edema Slide 34 Copyright © 2006 by Mosby, Inc.